**Study Overview:**
This study is testing a medication called solriamfetol to see if it helps teenagers with ADHD. ADHD stands for *Attention Deficit Hyperactivity Disorder*, which makes it hard for someone to pay attention and sit still. The study is called "FOCUS-3" and lasts for **6 weeks**. Participants will either take solriamfetol or a placebo, which is a pill that looks the same but doesn’t have any medicine in it.
**Key Points:**
- **Duration & Visits:** The study lasts for **6 weeks**. The number of doctor visits depends on the study site.
- **Who Can Join:** Teens aged **12 to under 18** with ADHD can join if they have consent from their parents or guardians.
- **Safety & Efficacy:** The study will check if solriamfetol works and is safe.
To join, a teen must have a doctor’s confirmation of ADHD and agree to follow the study rules. They can’t join if they can’t follow the study plans or if the doctor thinks it’s not safe for them.
How understandable was the trial content above?
Hard to understand
Easy to understand